Source:http://linkedlifedata.com/resource/pubmed/id/12430147
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2002-11-13
|
| pubmed:abstractText |
To measure the fluence at tissue surface for patients in our Phase II clinical trial of motexafin lutetium (MLu)-mediated chest wall photodynamic therapy for recurrent breast carcinoma and to compare it to the calculated irradiance.
|
| pubmed:language |
eng
|
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:author | |
| pubmed:copyrightInfo |
Copyright 2002 Wiley-Liss, Inc.
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
305-12
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:articleTitle |
In vivo light dosimetry for motexafin lutetium-mediated PDT of recurrent breast cancer.
|
| pubmed:affiliation |
Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania 19104-4283, USA.
|